# Memantine and Intensive Speech-Language Therapy in Aphasia

> **NCT00640198** · PHASE4 · COMPLETED · sponsor: **Gabinete Berthier y Martínez** · enrollment: 28 (actual)

## Conditions studied

- Aphasia
- Stroke

## Interventions

- **DRUG:** memantine
- **BEHAVIORAL:** constraint-induced language therapy (CIAT)
- **DRUG:** memantine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00640198
- **Lead sponsor:** Gabinete Berthier y Martínez
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2008-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00640198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00640198, "Memantine and Intensive Speech-Language Therapy in Aphasia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00640198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*